Published on
January 5, 2026
- 21:00 GMT
FDA approves first oral treatment for anemia in thalassemia, an inherited blood disorder
Action The U.S. Food and Drug Administration (FDA) approved Aqvesme (mitapivat) tablets to treat anemia (low levels of red blood cells) in adults with alpha- or beta-thalassemia. This is the first oral treatment option for patients with beta-thalassemia …
Distribution channels:
Healthcare & Pharmaceuticals Industry
